Clinical Trial Update: Alternate Day Buprenorphine Administration, Phase XI - 16 [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating alternate-day buprenorphine administration for opioid-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED